Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular aspects of scleroderma.

Maria Trojanowska1

  • 1Division of Rheumatology and Immunology, Medical University of South Carolina, 96 Jonathan Lucas St., Suite 912, Charleston, SC 29425, USA. trojanme@musc.edu

Frontiers in Bioscience : a Journal and Virtual Library
|February 28, 2002
PubMed
Summary

Scleroderma involves immune activation and fibrosis. This review focuses on scleroderma fibroblast biology, exploring how transforming growth factor-beta (TGF-beta) and connective tissue growth factor (CTGF) drive abnormal collagen deposition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

STUB1-mediated ubiquitination regulates Fli-1 stability and CD4⁺T cell activation during inflammation.

Molecular medicine (Cambridge, Mass.)·2026
Same author

Mechanisms of fibrotic tissue remodelling: insights from systemic sclerosis.

Nature reviews. Rheumatology·2026
Same author

Endothelial <i>GATA6</i> deficiency suppresses intracellular TLR3-interferon signaling in HPAECs and promotes interferon response in HPASMCs.

bioRxiv : the preprint server for biology·2025
Same author

Transcriptomic profiling of scleroderma monocytes reveals links with cardiovascular complications, implicating Notch and interferon pathways.

Journal of scleroderma and related disorders·2025
Same author

Publisher Correction: An international perspective on the future of systemic sclerosis research.

Nature reviews. Rheumatology·2025
Same author

An international perspective on the future of systemic sclerosis research.

Nature reviews. Rheumatology·2025

Area of Science:

  • Fibrosis research
  • Connective tissue disorders
  • Immunodermatology

Background:

  • Scleroderma is a complex autoimmune disease.
  • Characterized by immune system activation, vasculopathy, and fibrosis.
  • Fibrosis involves abnormal extracellular matrix (ECM) deposition.

Purpose of the Study:

  • To review scleroderma fibroblast biology.
  • To examine cellular and molecular mechanisms of abnormal collagen deposition.
  • To discuss ECM regulation in scleroderma.

Main Methods:

  • Literature review focusing on fibroblast biology.
  • Analysis of molecular mechanisms in fibrosis.
  • Examination of growth factors and transcription factors.

Related Experiment Videos

Main Results:

  • Scleroderma fibroblasts exhibit abnormal ECM regulation.
  • Transforming growth factor-beta (TGF-beta) and connective tissue growth factor (CTGF) play key roles.
  • Transcription factors regulate collagen gene expression (COL1A2).

Conclusions:

  • Scleroderma fibroblast biology is central to disease pathogenesis.
  • TGF-beta and CTGF are critical mediators of fibrosis.
  • Understanding these mechanisms may lead to targeted therapies.